He was treated with high-dose Solu-Medrol on [**2113-4-20**] and [**2113-4-21**] on outpatient setting in hopes of temporization of the disease so that they could safely return to the [**State **] into the care of his primary Oncologist.
His neck pain resolved without an intervention approximately 20 minutes after his arrival.
He denied any nausea, vomiting, palpitations, fevers, chills, abdominal pain, hemoptysis, dysphagia, throat pain, wheeze, or stridor.
He was also seen by the Vascular Surgery Service, who recommended a carotid ultrasound.
Prior to leaving the Emergency Department, he received allopurinol 300 mg p.o.
x 1, Decadron 40 mg p.o.
PAST MEDICAL HISTORY:  Non-Hodgkin lymphoma, diffuse large B- cell type, diagnosed in [**2108-9-12**], status post  R-CHOP, and XRT to the groin in [**2112-8-12**], status post DHAP in 8, [**2112**].
He is status post repeat cycles of R-CHOP in [**10/2108**] and through 02/[**2109**].
Status post treatment with Taxol, topotecan, and Rituxan from [**12/2110**] to 04/[**2111**].
Status post treatment with Rituxan and gemcitabine in [**4-/2112**] to 07/[**2112**].
Status post repeat treatment with DHAP in [**2113-3-3**] to [**2113-3-6**].
Status post two cycles of Rituxan in [**2113-3-13**].
History of DVT and PE status post six weeks of Coumadin therapy, originally diagnosed in [**2113-1-12**].
Coronary artery disease, status post CABG times four vessels in [**2105**].
Status post transurethral resection of prostate.
ALLERGIES:  The patient was allergic to ciprofloxacin resulting in hives, Vicodin resulting in dehydration, and Humibid resulting in hives.
Allopurinol 300 mg p.o.
Digoxin 0.25 mg p.o.
Aspirin 81 mg p.o.
Multivitamin one p.o.
Vitamin D. 6.
Neck exam remarkable for a large left-sided neck mass, thick 12 X 10 cm with deviation in the trachea to the right.
The patient also had a well-healed median sternotomy scar.
Serum chemistry showed sodium 138, potassium 4.2, chloride 102, bicarbonate 27, BUN 17, creatinine 0.8, glucose 156, calcium 8.8, phosphorus 3.0, magnesium 1.9, and uric acid 3.1.
The patient received IV Decadron and Anzemet in the Emergency Department for preparation of the second cycle of DHAP, which consisted of Decadron, cytarabine, and cisplatin.
This will be completed with vigorous hydration, allopurinol, and serial checks of tumor lysis labs.
He was supported with blood products.
He was felt stable for discharge and travel back to [**State **] and with resume care with his primary Oncologist there.
It was reiterated to the patient several times that at this time he was not a candidate for moment in clinical trial regarding treatment with Zevelin and in light of his rapidly progressive bulky disease, or he might be never be a candidate for such treatment.
The patient was started on heparin and Coumadin when he was in the Medical Intensive Care Unit, it is unclear if the right deep vein thrombosis was old or new, I have concern for pulmonary embolus.
As the patient's CT was negative, he was switched Lovenox and we will continue this as an outpatient.
After chemotherapy was complete, his neck mass had decreased in size somewhat.
He was instructed to continue digoxin and Lopressor.
DISCHARGE DIAGNOSES:  Non-Hodgkin B-cell lymphoma.
Coronary artery disease, status post coronary artery bypass grafting.
Status post transurethral resection of the prostate.
Compazine 10 mg p.o.
Reglan 10 mg p.o.
Decadron 20 mg p.o.
